Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Interview with Richard Pazdur, MD
lungcanc
Q & A with Dr. Laura Bierut
lungcanc
Afatinib Outperforms Gefitinib in Advanced Non-Small Cell Lung Cancer
lungcanc
Best of the 16th WCLC in Athens, Greece
lungcanc
FDA Corner – Interview with Gideon Blumenthal, MD
lungcanc
NCI Corner – Interview with Shakun Malik, MD
lungcanc
Implementation of Lung Cancer CT Screening: A Global Dream or a...
lungcanc
Clinicians and Tobacco—What Can We Really Do?
lungcanc
Lung Cancer Survivor Wins Trip to US NFL 2016 Pro Bowl
lungcanc
Memoir Resonates with Oncologists and Patients with Lung Cancer
lungcanc
1
...
50
51
52
53
Page 51 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS